Brief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
25/03/2025 10:16
March 25 (Reuters) - Tianda Pharmaceuticals Ltd 0455.HK: LOSS ATTRIBUTABLE EXPECTED TO INCREASE TO HK$61 MILLION FOR FY LOSS DUE TO HK$1.3 MILLION GOODWILL IMPAIRMENT IN FY, OTHERS Further company coverage: 0455.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianda Pharmaceuticals
See all newsBrief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA